MAPT and diabetes mellitus: Therefore, Insulin deregulation resulting in decrease of PP2A activity and tau hyperphosphorylation might explain the higher tau phosphorylation and pathology found in T2DM patients and could underlie, at least in part, the high risk od AD in DM patients.